Medplus Share Price Target 2022 , 2023 , 2024 , 2025 & 2030

Medplus Share Price Target Health’s IPO price is set at between 780 and 796 rupees per share. Medplus Health Services Limited will be listed on BSE and NSE. Prior to the listing of NSE and BSE, the gray market premium on MedPlus Health’s stock was Rs. To date, more than 1 billion MedPlus Health shares have been traded on the National Stock Exchange and more than 9,000 shares have been traded on the Bombay Stock Exchange.

Therefore, we hope you learn all the details about MedPlus Health’s IPO status, stock price and GMP 2021 in the above article. In fiscal year 2021, based on the operating income of Chennai, Bangalore, Hyderabad, and Kolkata, its share of organized pharmacy retail is 30%, 29%, 30%, and 22%, respectively.

Medplus Share Price Target 2022 , 2023 , 2024 , 2025 & 2030

Medplus Share Price

According to forecasts for Yes Bank shares provided by stock market experts, its target price for the near future is 18 rupees, and as soon as this level goes beyond this level, there may be new momentum for the next 2 or 3 rupees. Yes Bank’s share price history for the past month suggests that the private lender bank’s shares reached a minimum closing level of INR 15.60, while the maximum closing price was INR 16.60.

Medplus Healths’ IPO status is available on the BSE India website and on the KFintech India Private Limited registrar website. Medplus Health India Pvt Limited is now finalizing its IPO spin-off, which can be verified online through the official BSE portal or the registrar portal.

Medplus Share Price Target 2022 , 2023 , 2024 , 2025 & 2030

The shares were quoted at Rs 1,015 with a 27.51% premium over the initial public offering (IPO) price. Buy shares at a discount of Rs 78 per share from the final offer price. Here we have updated all the details such as IPO date, share price, offers received, gray market premium (GMP), etc. The agency has updated the target price to Rs 5,000, implying a 47% increase from the previous day’s price to 3429 rupees on the BSE.

The BSE’s overall market volume was also strong, with 2,323 shares rising from 1,240 shares down, while 171 shares remained unchanged. While the sustainability of this margin is an issue, the IPO price also appears to be overpriced. Medplus posted a profit of Rs 63.11 billion in 21 fiscal years, up from Rs 1.79 billion a year earlier.

As part of the placement, employees of the company will receive stock holdings of Rs 5 billion. While the company managed to get only ~ 5% due to price increases, another one is planned for the 2nd quarter of 22E. Assuming the open offer and cancellation of all Treasury shares are successful, Kubotas’ stake in ESC rises to 53.5%. The stock surpassed the previous high of Rs 1,848, set on October 20 this year.

Meanwhile, European stocks were also higher in early trading on Thursday, although Omicron cases rose globally and other countries announced restrictions to contain the spread of the virus. Like other metals stocks, this stock is also drifting, setting a new high of Rs 551.85 in October. This website uses a security service to protect against online attacks. Overseas, Asian stocks closed higher on Thursday following strong signals from Wall Street and positive reports on the potential impact of the Omicron option on the global economy.

As the non-farm tractor segment will grow faster than the agricultural tractor segment in FY22, product range (in terms of hp) should normalize back to previous levels.

Leave a Comment